Prospective Comparison of Ventilatory Equivalent Versus Peak Oxygen Consumption in Predicting Outcomes of Patients With Heart Failure

American Journal of Cardiology

Volumn 97, Issue 11, 2006, Pages 1607-1610

  Stolker, Joshua M ^a   Heere, Bastiaan ^a   Geltman, Edward M ^a   Schechtman, Kenneth B ^a   Peterson, Linda R ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; ARTICLE; CONTROLLED STUDY; DEATH; DEFIBRILLATOR; FEMALE; FOLLOW UP; HEART FAILURE; HEART RATE; HEART TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PRIORITY JOURNAL; SURVIVAL; SYSTOLIC BLOOD PRESSURE; TREADMILL EXERCISE;

DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; INSPIRATORY CAPACITY; MALE; MIDDLE AGED; OXYGEN CONSUMPTION; PROGNOSIS; PROSPECTIVE STUDIES;

EID: 33646678009     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2005.12.053     Document Type: Article

References (17)

1. Mancini D., LeJemtel T., and Aaronson K. Peak VO2. a simple yet enduring standard. Circulation 101 (2000) 1080-1082
2. Szlachcic J., Massie B.M., Kramer B.L., Topic N., and Tubau J. Correlates and prognostic implication of exercise capacity in chronic congestive heart failure. Am J Cardiol 55 (1985) 1037-1042
3. Likoff M.J., Chandler S.L., and Kay H.R. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic or dilated cardiomyopathy. Am J Cardiol 59 (1987) 634-638
4. Mancini D.M., Eisen H., Kussmaul W., Mull R., Edmunds Jr. L.H., and Wilson J.R. Value of peak exercise oxygen consumption for optimal timing of cardiac transplantation in ambulatory patients with heart failure. Circulation 83 (1991) 778-786
5. Hunt S.A., Abraham W.T., Chin M.H., Feldman A.M., Francis G.S., Ganiats T.G., Jessup M., Konstam M.A., Mancini D.M., Michl K., et al. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult-summary article. J Am Coll Cardiol 46 (2005) 1116-1143
6. Peterson L.R., Schechtman K.B., Ewald G.A., Geltman E.M., Meyer T., Krekeler P., and Rogers J.G. The effect of beta-adrenergic blockers on the prognostic value of peak exercise oxygen uptake in patients with heart failure. J Heart Lung Transplant 22 (2003) 70-77
7. Metra M., Giubbini R., Nodari S., Boldi E., Modena M.G., and Dei Cas L. Differential effects of beta blockers in patients with heart failure. a prospective, randomized, double-blind comparison of the long-term effects of metoprolol versus carvedilol. Circulation 102 (2000) 546-551
8. Peterson L.R., Schechtman K.B., Ewald G.A., Geltman E.M., de las Fuentes L., Meyer T., Krekeler P., Moore M.L., and Rogers J.G. Timing of cardiac transplantation in patients with heart failure receiving beta-adrenergic blockers. J Heart Lung Transplant 22 (2003) 1141-1148
9. MacGowan G.A., Janosko K., Cecchetti A., and Murali S. Exercise-related ventilatory abnormalities and survival in congestive heart failure. Am J Cardiol 79 (1997) 1264-1266
10. Goldman L., Hashimoto B., Cook E.F., and Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class. advantages of a new specific activity scale. Circulation 64 (1981) 1227-1234
11. Kohrt W.M., Malley M.T., Coggan A.R., Spina R.J., Ogawa T., Ehsani A.A., Bourey R.E., Martin W.H., and Holloszy J.O. Effects of gender, age, and fitness level on the responses of VO2max to training in 60-71 year-olds. J Appl Physiol 71 (1991) 2004-2011
12. MacGowan G.A., Cecchetti A., and Murali S. Ventilatory drive during exercise in congestive heart failure. J Card Failure 3 (1997) 257-262
13. MacGowan G.A., Panzak G., and Murali S. Exercise-related ventilatory abnormalities are more specific for functional impairment in chronic heart failure than reduction in peak exercise oxygen consumption. J Heart Lung Transplant 20 (2001) 1167-1173
14. Moss A.J., Zareba W., Hall W.J., Klein H., Wilber D.J., Cannom D.S., Daubert J.P., Higgins S.L., Brown M.W., Andrews M.L., and Multicenter Automatic Defibrillator Implantation Trial II Investigators. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 346 (2002) 877-883
15. Bardy G.H., Lee K.L., Mark D.B., Poole J.E., Packer D.L., Boineau R., Domanski M., Troutman C., Anderson J., Johnson G., et al., Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT) Investigators. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 352 (2005) 225-237
16. Lechat P.P. Beta-blocker efficacy according to heart rate and rhythm in patients with heart failure. commentary on the Cardiac Insufficiency Bisoprolol Study II analysis. Card Electrophysiol Rev 7 (2003) 233-235
17. Wikstrand J., Hjalmarson A., Waagstein F., Fagerberg B., Goldstein S., Kjekshus J., Wedel H., and MERIT-HF Study Group. Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure. analysis of the experience in Metoprolol CR/XL Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF). J Am Coll Cardiol 40 (2002) 491-498